Q2 2019 Earnings Release

July 24, 2019

Latest Releases

Genomma Lab Signs Exclusive License to Market NOVAMIL and NOVALAC in Mexico

September 12, 2019

Placement of MX$300 Million Through Two Unsecured Local Bond Offerings

September 5, 2019

Genomma´s OTC Manufacturing Plant Receives COFEPRIS Sanitary License

July 15, 2019

2017 Annual Report Retransmission (Spanish Only)

May 24, 2019

2018 Annual Report

April, 2019

pdf